Minireviews
Copyright ©The Author(s) 2015.
World J Hepatol. Jul 28, 2015; 7(15): 1953-1963
Published online Jul 28, 2015. doi: 10.4254/wjh.v7.i15.1953
Figure 1
Figure 1 Sustained virologic response of various treatment regimens. DAAs: Direct acting antivirals; RBV: Ribavirin; Peg-IFN: Pegylated interferon.
Figure 2
Figure 2 Cirrhotic patients in the fusion trial. SOF: Sofosbuvir; RBV: Ribavirin.